{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT02364999",
      "briefTitle": "PALOMA-2: Phase III Trial of Palbociclib (PD-03329901) Plus Letrozole Versus Placebo Plus Letrozole for ER+",
      "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Palbociclib (PD-03329901) Plus Letrozole Versus Placebo Plus Letrozole for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer",
      "organization": {
        "name": "Pfizer"
      }
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n• Postmenopausal women with HR+, HER2- MBC\n• No prior systemic therapy for MBC\n• Measurable disease per RECIST 1.1\n• ECOG PS 0-1\n• Adequate organ function\n\nExclusion Criteria:\n• Prior chemotherapy for MBC\n• Active CNS metastases\n• QTc prolongation\n• Severe hepatic impairment",
      "sex": "Female",
      "minimumAge": "18 Years",
      "maximumAge": "No maximum",
      "healthyVolunteers": false,
      "stdAges": ["Adult", "Older Adult"]
    },
    "conditionsModule": {
      "conditions": ["Breast Cancer", "Metastatic Breast Cancer"]
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Palbociclib + Letrozole",
          "type": "Experimental",
          "description": "Palbociclib 125mg daily + Letrozole 2.5mg daily"
        },
        {
          "label": "Placebo + Letrozole",
          "type": "Placebo Comparator",
          "description": "Placebo + Letrozole 2.5mg daily"
        }
      ],
      "interventions": [
        {
          "type": "Drug",
          "name": "Palbociclib",
          "description": "CDK4/6 inhibitor"
        },
        {
          "type": "Drug",
          "name": "Letrozole",
          "description": "Aromatase inhibitor"
        }
      ]
    },
    "designModule": {
      "studyType": "Interventional",
      "phases": ["Phase 3"],
      "designInfo": {
        "allocation": "Randomized",
        "interventionModel": "Parallel Assignment",
        "primaryPurpose": "Treatment",
        "maskingInfo": {
          "masking": "Double",
          "whoMasked": ["Participant", "Investigator"]
        }
      }
    },
    "statusModule": {
      "overallStatus": "Completed",
      "startDateStruct": {
        "date": "2015-03"
      },
      "primaryCompletionDateStruct": {
        "date": "2016-06"
      }
    }
  },
  "hasResults": true,
  "studyType": "Interventional",
  "overallStatus": "Completed",
  "phase": "Phase 3"
}